Literature DB >> 6707378

Cardiac rhythm and conduction in Duchenne's muscular dystrophy: a prospective study of 20 patients.

J K Perloff.   

Abstract

This study was designed to determine the types and prevalence of rhythm and conduction disturbances in Duchenne's muscular dystrophy, and examine the results in light of known morphologic abnormalities of the myocardium and the small coronary arteries, and in the context of left ventricular function, regional wall motion, mitral valve prolapse and left atrial size. The observed disorders of impulse and conduction extended from the sinus node to the His-Purkinje system. Rhythm disturbances included persistent and labile sinus tachycardia (gradual or abrupt), sinus arrhythmia, sinus pauses, atrial ectopic beats, atrial ectopic rhythm, junctional rhythm, atrial flutter and ventricular premature beats (uniform, multiform, bigeminal and repetitive). Disorders of conduction included abnormal intraatrial or interatrial conduction, Mobitz type I block, nonconducted atrial premature beats, short PR interval, right ventricular conduction delay and rightward axis compatible with left posterior fascicular block. The role of dystrophic involvement of specialized conduction tissues and of the small vessel coronary arteriopathy remains speculative, but mitral valve prolapse, left atrial size and left ventricular size, function and regional wall motion played no discernible part in the genesis of the rhythm and conduction disturbances. Except for end-stage atrial flutter, these disturbances were not clinically deleterious.

Entities:  

Mesh:

Year:  1984        PMID: 6707378     DOI: 10.1016/s0735-1097(84)80186-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  23 in total

1.  Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs.

Authors:  Deborah M Fine; Jin-Hong Shin; Yongping Yue; Dietrich Volkmann; Stacey B Leach; Bruce F Smith; Mark McIntosh; Dongsheng Duan
Journal:  Neuromuscul Disord       Date:  2011-05-13       Impact factor: 4.296

2.  Limb girdle type muscular dystrophy associated with a Wolff-Parkinson-White syndrome.

Authors:  R Weissleder; A Marfil; H R Martinez; R A Rangel-Guerra
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-04       Impact factor: 10.154

3.  Cardiovascular Complications of Neuromuscular Disorders.

Authors:  Bhavesh Sachdev; Perry M. Elliott; William J. McKenna
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-04

4.  Dystrophin predominantly localizes to the transverse tubule/Z-line regions of single ventricular myocytes and exhibits distinct associations with the membrane.

Authors:  V Peri; B Ajdukovic; P Holland; B S Tuana
Journal:  Mol Cell Biochem       Date:  1994-01-12       Impact factor: 3.396

5.  Complications during anaesthesia in patients with Duchenne's muscular dystrophy (a retrospective study)

Authors:  U T Larsen; B Juhl; O Hein-Sörensen; B de Fine Olivarius
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

6.  Suitable analyzed signal duration and criteria for abnormal signal-averaged electrocardiogram on frequency-domain analysis in patients with Duchenne's muscular dystrophy.

Authors:  M Kubo; S Matsuoka; Y Kuroda
Journal:  Pediatr Cardiol       Date:  1996 Mar-Apr       Impact factor: 1.655

7.  Cardiomyopathy of Duchenne muscular dystrophy.

Authors:  L D'Orsogna; J P O'Shea; G Miller
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

8.  Clinical significance of late potential in patients with Duchenne muscular dystrophy.

Authors:  M Kubo; S Matsuoka; Y Taguchi; H Akita; Y Kuroda
Journal:  Pediatr Cardiol       Date:  1993-10       Impact factor: 1.655

9.  Cardiac electrophysiological characteristics of the mdx ( 5cv ) mouse model of Duchenne muscular dystrophy.

Authors:  Dorothy M Branco; Cordula M Wolf; Megan Sherwood; Peter E Hammer; Peter B Kang; Charles I Berul
Journal:  J Interv Card Electrophysiol       Date:  2007-10-17       Impact factor: 1.900

10.  AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy.

Authors:  Brian Bostick; Jin-Hong Shin; Yongping Yue; Nalinda B Wasala; Yi Lai; Dongsheng Duan
Journal:  J Mol Cell Cardiol       Date:  2012-05-12       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.